|
Model Number 11500A |
Device Problems
Perivalvular Leak (1457); Detachment of Device or Device Component (2907)
|
Patient Problem
Heart Failure/Congestive Heart Failure (4446)
|
Event Date 09/22/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
H10: additional manufacturer narrative: the investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|
|
Event Description
|
It was learned through implant patient registry and investigation that a 27mm 11500a aortic valve was explanted after an implant duration of 2 years, 3 months due to valve dehiscence and severe large perivalvular leak.The explanted valve was replaced with a 25mm 11060a aortic valved-conduit.Per medical records, the patient presented with acute systolic heart failure secondary to paravalvular aortic insufficiency and underwent a redo avr and redo total aortic root replacement.Intraoperatively the aortic valve had completely separated from the aortic annulus and is free-floating with a large peri-graft hematoma.Essentially previous repair had completely dehisced.There was a huge inflammatory rind around the graft and valve.The tissue around the true aortic annulus was in reasonable condition.Multiple pledgeted sutures were placed in the annulus and a 25mm 11060a aortic valved-conduit was implanted with graft reconstruction of both coronary arteries.Post repair the avc was well-seated with no evidence of periprosthetic insufficiency.The patient was separated from bypass, coagulopathy was extensive as there were multiple areas of inflamed tissue.The patient tolerated the procedure well, after hemostasis was achieved, he was transferred to the cardiovascular recovery unit in serious but stable condition.
|
|
Manufacturer Narrative
|
Device dehiscence may occur early or late.When it occurs in the early post-operative period, it is typically a result of inadequate device implantation in combination with friable myocardial tissue.Late dehiscence can occur as a result of successive dilatation of cardiac structures that result from progression of disease.Valve dehiscence is not a malfunction related to a manufacturing deficiency of the device.The root cause of this event was determined to be due to patient related factors, including the patient's friable tissue.The event in this case was impacted by the progression of the patient's underlying valvular disease pathology with nonstructural dysfunction.The subject device is not available for evaluation as it was discarded.The device history record (dhr) review was completed and this device passed all manufacturing and sterilization inspections prior to release for distribution.There were no issues identified that would have impacted this event.There was no allegation of a malfunction which could be related to a manufacturing non-conformance; no labeling non-conformance/deficiency; no use-related issue with a hazardous situation; no device-related infection; and there is no evidence of a product failure with regard to design, reliability, or use error.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|
|
Search Alerts/Recalls
|
|
|